Clinical Trial Update: Use Art-assist and Neupogen to Treat Chronic Limb Ischemia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Art-assist and Neupogen for chronic limb ischemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb Ischemia

Drugs mentioned

• Art-assist
• Neupogen (Filgrastim)

Snippet

Sponsor: University of Chicago | Conditions: Lower Limb Ischemia | Phase 4 | Status: WITHDRAWN